by Support | Jul 14, 2020 | News
For Marcus*, the shrooms trip that changed his life also turned him into a tree. There, in the middle of the woods, he melted into a “pattern of sacred geometry that looked like a Persian rug” — an experience that connected him to the rest of the forest,...
by Support | Jun 10, 2020 | News
Robin Carhart-Harris is head of the Centre for Psychedelic Research at Imperial College London. At Imperial College we’ve been comparing psilocybin to conventional antidepressants – and the results are likely to be game-changing. The world is experiencing a...
by Support | May 25, 2020 | News
American’s attitudes toward marijuana have relaxed significantly in the last ten years, resulting in a wave of reform that has brought adult use legalization and medicinal cannabis to cities and states throughout the country. Could magic mushrooms have a moment? One...
by Support | May 7, 2020 | News
Even before COVID-19 set off a global tsunami of anxiety and depression, psychedelic drugs were already showing exciting promise for treating these and other intractable mental health conditions. Compass Pathway’s recent raise of $80M to expand research into the...
by Support | Apr 20, 2020 | News
The Miller School of Medicine at the University of Miami (UM) has received funding to study the combination of psilocybin and cannabidiol (CBD) for treating (and possibly preventing) traumatic brain injury (TBI) and post-traumatic stress disorder (PTSD) that often...
by Support | Mar 12, 2020 | Featured, News
TORONTO — Growing evidence about the powers of psilocybin, a naturally occurring psychedelic compound produced by several species of mushrooms, being used to treat anxiety and depression has inspired advocates to file a federal court challenge next month to...
